At 2 and 6 h post infection, both WT and Card9−/− BMDMs showed similar levels of cellular viability in the presence or absence of glibenclamide (Fig. 4a,b), while MCC950 slightly inhibited cell death in Card9−/− BMDM (Fig. 4e,f). This evidence concerns the gene CARD9 and infection.